NSE BSE
mukka proteins limited stock

MUKKA PROTEINS LIMITED Share Price

- - (%)
Sector: -

22980

544135

MUKKA

img img img img
No Data Available

MUKKA PROTEINS LIMITED Share Price Update


As of the latest trading session, MUKKA PROTEINS LIMITED share price is currently at 35.15, which is up by 0.20 from its previous closing. Today, the stock has fluctuated between 34.90 and 35.40. Over the past year, MUKKA PROTEINS LIMITED has achieved a return of 0.00 %. In the last month alone, the return has been -3.45 %.

MUKKA PROTEINS LIMITED Performance

Day Range

Low34.90 High35.40
35.10

52 Week Range

Low 33.00 High 43.95
35.10

Open Price

35.35

Prev. Close

34.95

Volume (Shares)

288273.00

Total traded value

101.18

Upper Circuit

36.65

Lower Circuit

33.20

Note: The current prices & values are delayed, Login to your account for live updates.

MUKKA PROTEINS LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 773.30
PE Ratio (TTM) 16.72
Book Value / Share 12.17
Beta 1.46
ROE 38.66%
EPS (TTM) 2.09
Dividend Yield 0.00%
Net Profit Qtr (Cr) 22.32

MUKKA PROTEINS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 223.92
Operating Expense 217.13
Net Profit 22.32
Net Profit Margin (%) 9.96
Earnings Per Share (EPS) 0.99
EBITDA 26.79
Effective Tax Rate (%) -24.97
Particulars DEC 2023 (Values in Cr)
Revenue 468.31
Operating Expense 478.85
Net Profit 9.05
Net Profit Margin (%) 1.93
Earnings Per Share (EPS) 0.41
EBITDA 20.00
Effective Tax Rate (%) 31.43
Particulars SEP 2023 (Values in Cr)
Revenue 307.37
Operating Expense 288.08
Net Profit 27.01
Net Profit Margin (%) 8.78
Earnings Per Share (EPS) 1.23
EBITDA 40.21
Effective Tax Rate (%) 17.87
Particulars JUN 2023 (Values in Cr)
Revenue 231.22
Operating Expense 0.00
Net Profit 4.38
Net Profit Margin (%) 1.89
Earnings Per Share (EPS) 0.15
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 353.55
Operating Expense 331.90
Net Profit 22.47
Net Profit Margin (%) 6.35
Earnings Per Share (EPS) 1.02
EBITDA 40.78
Effective Tax Rate (%) 32.74
Particulars MAR 2024 (Values in Cr)
Revenue 1230.82
Operating Expense 1216.97
Net Profit 62.76
Net Profit Margin (%) 5.09
Earnings Per Share (EPS) 2.78
EBITDA 101.46
Effective Tax Rate (%) 12.40
Particulars MAR 2023 (Values in Cr)
Revenue 1045.64
Operating Expense 1020.17
Net Profit 39.42
Net Profit Margin (%) 3.76
Earnings Per Share (EPS) 1.79
EBITDA 74.55
Effective Tax Rate (%) 28.43
Particulars MAR 2022 (Values in Cr)
Revenue 692.89
Operating Expense 672.43
Net Profit 19.82
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 0.90
EBITDA 31.91
Effective Tax Rate (%) 29.71
Particulars MAR 2021 (Values in Cr)
Revenue 536.25
Operating Expense 539.34
Net Profit 4.61
Net Profit Margin (%) 0.85
Earnings Per Share (EPS) 0.21
EBITDA 9.05
Effective Tax Rate (%) 23.92
Particulars MAR 2023 (Values in Cr)
Book Value / Share 6.72
ROE % 38.62
ROCE % 24.01
Total Debt to Total Equity 1.77
EBITDA Margin 8.01
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.47
ROE % 31.32
ROCE % 18.20
Total Debt to Total Equity 2.03
EBITDA Margin 7.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1209.53
ROE % 12.53
ROCE % 9.06
Total Debt to Total Equity 2.44
EBITDA Margin 4.58
Particulars MAR 2020 (Values in Cr)
Book Value / Share 1028.18
ROE % 23.25
ROCE % 14.96
Total Debt to Total Equity 2.23
EBITDA Margin 5.31
Particulars MAR 2019 (Values in Cr)
Book Value / Share 799.75
ROE % 31.10
ROCE % 18.15
Total Debt to Total Equity 1.88
EBITDA Margin 6.26
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.53
ROE % 38.66
ROCE % 23.13
Total Debt to Total Equity 1.96
EBITDA Margin 6.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.74
ROE % 27.31
ROCE % 16.76
Total Debt to Total Equity 1.99
EBITDA Margin 5.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1142.93
ROE % 4.29
ROCE % 5.81
Total Debt to Total Equity 1.98
EBITDA Margin 2.51
Particulars MAR 2020 (Values in Cr)
Book Value / Share 1046.08
ROE % 20.71
ROCE % 14.99
Total Debt to Total Equity 1.87
EBITDA Margin 4.65
Particulars MAR 2019 (Values in Cr)
Book Value / Share 823.55
ROE % 34.02
ROCE % 19.12
Total Debt to Total Equity 1.79
EBITDA Margin 6.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 29.01
Total Assets 575.16
Total Liabilities 575.16
Total Equity 155.84
Share Outstanding 220000000
Price to Book Ratio 0.00
Return on Assets (%) 7.66
Return on Capital (%) 10.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 13.89
Total Assets 392.29
Total Liabilities 392.29
Total Equity 103.07
Share Outstanding 220000000
Price to Book Ratio 0.00
Return on Assets (%) 6.17
Return on Capital (%) 8.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.18
Total Assets 354.79
Total Liabilities 354.79
Total Equity 69.92
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 2.52
Return on Capital (%) 3.92
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.65
Total Assets 293.11
Total Liabilities 293.11
Total Equity 57.75
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 4.49
Return on Capital (%) 6.61
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 200.84
Total Liabilities 200.84
Total Equity 44.09
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 7.11
Return on Capital (%) 11.25
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 23.02
Total Assets 500.03
Total Liabilities 500.03
Total Equity 121.63
Share Outstanding 220000000
Price to Book Ratio 0.00
Return on Assets (%) 7.88
Return on Capital (%) 11.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.10
Total Assets 329.07
Total Liabilities 329.07
Total Equity 82.28
Share Outstanding 220000000
Price to Book Ratio 0.00
Return on Assets (%) 6.02
Return on Capital (%) 8.16
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.07
Total Assets 288.38
Total Liabilities 288.38
Total Equity 62.86
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 1.59
Return on Capital (%) 2.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.89
Total Assets 257.37
Total Liabilities 257.37
Total Equity 57.53
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 4.98
Return on Capital (%) 7.73
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 196.66
Total Liabilities 196.66
Total Equity 45.29
Share Outstanding 550000
Price to Book Ratio 0.00
Return on Assets (%) 7.83
Return on Capital (%) 12.22
Particulars MAR 2023 (Values in Cr)
Net Income 65.94
Cash from Operations -45.19
Cash from Investing -2.30
Cash from Financing 74.66
Net change in Cash 15.01
Free Cash Flow -36.97
Particulars MAR 2022 (Values in Cr)
Net Income 35.98
Cash from Operations 10.55
Cash from Investing -11.47
Cash from Financing 14.99
Net change in Cash 8.38
Free Cash Flow 17.06
Particulars MAR 2021 (Values in Cr)
Net Income 15.45
Cash from Operations 6.37
Cash from Investing -13.61
Cash from Financing 13.48
Net change in Cash 1.66
Free Cash Flow 17.05
Particulars MAR 2020 (Values in Cr)
Net Income 19.73
Cash from Operations -19.17
Cash from Investing -27.97
Cash from Financing 53.78
Net change in Cash 0.74
Free Cash Flow 17.22
Particulars MAR 2019 (Values in Cr)
Net Income 18.80
Cash from Operations -15.73
Cash from Investing -23.16
Cash from Financing 34.19
Net change in Cash -9.23
Free Cash Flow 3.31
Particulars MAR 2023 (Values in Cr)
Net Income 55.09
Cash from Operations -38.27
Cash from Investing 0.71
Cash from Financing 61.11
Net change in Cash 14.87
Free Cash Flow -34.95
Particulars MAR 2022 (Values in Cr)
Net Income 28.19
Cash from Operations -12.96
Cash from Investing -7.24
Cash from Financing 27.25
Net change in Cash 4.70
Free Cash Flow -10.60
Particulars MAR 2021 (Values in Cr)
Net Income 6.05
Cash from Operations 1.95
Cash from Investing -5.41
Cash from Financing 8.05
Net change in Cash 0.30
Free Cash Flow 7.36
Particulars MAR 2020 (Values in Cr)
Net Income 18.81
Cash from Operations -18.30
Cash from Investing 1.81
Cash from Financing 22.63
Net change in Cash 0.38
Free Cash Flow -12.59
Particulars MAR 2019 (Values in Cr)
Net Income 20.52
Cash from Operations -17.04
Cash from Investing -19.44
Cash from Financing 31.38
Net change in Cash -9.63
Free Cash Flow -3.48
Company Name Price P/E P/B Market Cap 52 Week Low/High
MUKKA PROTEINS LIMITED 34.94 14.93 2.64 1048.20 32.50 / 44.00
Mukka Proteins Ltd 29.00 0.00 -0.52 18.86 0.00 / 0.00
JAYKAY ENTERPRISES LTD. 130.75 88.95 4.26 764.33 41.80 / 169.00
MODI RUBBER LTD 97.00 15.57 0.37 242.89 59.01 / 119.00
THOMAS COOK (INDIA) LTD 213.35 38.79 6.60 10040.02 59.47 / 228.15
Company Name Price P/E P/B Market Cap 52 Week Low/High
MUKKA PROTEINS LIMITED 34.94 16.72 2.87 1048.20 32.50 / 44.00
Mukka Proteins Ltd 29.00 0.00 -0.53 18.86 0.00 / 0.00
FGP LTD. 9.31 42.32 3.27 11.08 4.30 / 9.32
JAYKAY ENTERPRISES LTD. 130.75 59.16 4.74 764.33 41.80 / 169.00
MPIL CORPORATION LTD. 589.95 50.95 2.17 33.63 217.55 / 1264.05

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 35.10
  • 26 Days 36.00
  • 10 Days 35.40
  • 50 Days 37.30
  • 12 Days 35.50
  • 100 Days 38.90
  • 20 Days 35.70
  • 200 Days 42.00
35.00
PIVOT
First Resistance 35.30
Second Resistance 35.65
Third Resistance 35.95
First Support 34.65
Second Support 34.35
Third Support 34.00
RSI 31.73
MACD -0.54
Commodity Channel Index (CCI) -99.88
ADX 14.43
Williams % R -88.16

Over 1 Month

down

-3.45

Over 3 Months

down

-17.27

Over 6 Months

down

0.00

Over 1 Year

down

0.00

Over 3 Years

down

0.00

Over 5 Years

down

0.00

MUKKA PROTEINS LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MUKKA PROTEINS LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
20.2
Promoter Holdings
73.33
FII
6.46
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Mohammed Haris K Shareholding of Promoter and Promoter Group 9.06868E7 30.23
K Mohammad Arif Shareholding of Promoter and Promoter Group 4.84004E7 16.13
K Mohammed Althaf Shareholding of Promoter and Promoter Group 4.84004E7 16.13
Kalandan Abdul Razak Shareholding of Promoter and Promoter Group 2.2E7 7.33
Umaiyya Banu Shareholding of Promoter and Promoter Group 1.05112E7 3.5
Neomile Growth Fund - Series I Public Shareholding 5950828.0 1.98
Eminence Global Fund Pcc- Eubilia Capital Partners Fund I Public Shareholding 3929040.0 1.31
Craft Emerging Market Fund Pcc- Elite Capital Fund Public Shareholding 3656299.0 1.22
Elara India Opportunities Fund Limited Public Shareholding 3599840.0 1.2
Saint Capital Fund Public Shareholding 3573800.0 1.19
Zinnia Global Fund Pcc - Cell Dewcap Fund Public Shareholding 3571660.0 1.19
Aisha Shabnam Shareholding of Promoter and Promoter Group 400.0 0.0
Razeena Khatheeja Shareholding of Promoter and Promoter Group 400.0 0.0
Zareena Banu Shareholding of Promoter and Promoter Group 400.0 0.0

MUKKA PROTEINS LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About MUKKA PROTEINS LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MUKKA PROTEINS LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Mukka Proteins Ltd?

Answer Field

The share price of Mukka Proteins Ltd for NSE is ₹ 35.15 and for BSE is ₹ 35.3.

What is the Market Cap of Mukka Proteins Ltd?

Answer Field

The market cap of Mukka Proteins Ltd for NSE is ₹ 773.30 Cr. and for BSE is ₹ 776.60 Cr. as of now.

What is the 52 Week High and Low of Mukka Proteins Ltd?

Answer Field

The 52 Week High and Low of Mukka Proteins Ltd for NSE is ₹ 43.95 and ₹ 33.00 and for BSE is ₹ 44.00 and ₹ 32.50.

How to Buy Mukka Proteins Ltd share?

Answer Field

You can trade in Mukka Proteins Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Mukka Proteins Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader